Lorem Ipsum

Laurent Pharmaceuticals announces positive outcomes of pre-planned interim DSMB safety review and futility analysis for phase 2 RESOLUTION study in hospitalized COVID-19 patients.

Read more here.

 Lorem Ipsum

Laurent Pharmaceuticals announces positive outcomes of pre-planned interim DSMB safety review and futility analysis for phase 2 RESOLUTION study in hospitalized COVID-19 patients.

Read more here.